Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

403 ARTÍCULOS , VIENDO DEL 16 AL 30

Cognitive-motor intervention in Alzheimer's disease: long-term results from the Maria Wolff trial

Muñiz R, Serra CM, Reisberg B, Rojo JM, Del Ser T, Peña Casanova J, Olazarán J.

J Alzheimers Dis. 2015;45(1):295-304. doi: 10.3233/JAD-142364.

18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease

Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D.

Clin Nucl Med. 2015 Feb;40(2):e111-6. doi: 10.1097/RLU.0000000000000666.

Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease

Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR.

J Alzheimers Dis. 2015;44(2):705-20. doi: 10.3233/JAD-142874.

Cerebrospinal fluid total prion protein: a potential in vivo marker of cerebral prion pathology

Zetterberg H.

JAMA Neurol. 2015 Mar;72(3):261-3. doi: 10.1001/jamaneurol.2014.4078.

The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease

Phillips C, Baktir MA, Das D, Lin B, Salehi A.

Phys Ther. 2015 Jul;95(7):1046-60. doi: 10.2522/ptj.20140212. Epub 2015 Jan 8.

A disease that strikes close to home

Hickner J.

J Fam Pract. 2015 Jan;64(1):8.

Hemiparkinsonism-hemiatrophy syndrome with Alzheimer's disease

Yang Y, Kwak YT.

Geriatr Gerontol Int. 2015 Jan;15(1):122-3. doi: 10.1111/ggi.12279.

The effectiveness of reality orientation in the treatment of Alzheimer's disease

Camargo CH, Justus FF, Retzlaff G.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):527-32. doi: 10.1177/1533317514568004. Epub 2015 Jan 14.

Left temporal lobe epilepsy revealing left posterior cortical atrophy due to Alzheimer's disease

Cretin B, Di Bitonto L, Blanc F, Magnin E.

J Alzheimers Dis. 2015;45(2):521-6. doi: 10.3233/JAD-141953.

A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease

Remington R, Bechtel C, Larsen D, Samar A, Doshanjh L, Fishman P, Luo Y, Smyers K, Page R, Morrell C, Shea TB.

J Alzheimers Dis. 2015;45(2):395-405. doi: 10.3233/JAD-142499.

Smell identification function and Alzheimer's disease: a selective review

Velayudhan L.

Curr Opin Psychiatry. 2015 Mar;28(2):173-9. doi: 10.1097/YCO.0000000000000146.

Theory of mind in behavioural-variant frontotemporal dementia and Alzheimer's disease: a meta-analysis

Bora E, Walterfang M, Velakoulis D.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):714-9. doi: 10.1136/jnnp-2014-309445. Epub 2015 Jan 16.

Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials

Xu J, Wang LL, Dammer EB, Li CB, Xu G, Chen SD, Wang G.

Am J Alzheimers Dis Other Demen. 2015 Aug;30(5):439-47. doi: 10.1177/1533317514568005.

View-centralized multi-atlas classification for Alzheimer's disease diagnosis

Liu M, Zhang D, Shen D; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2015 May;36(5):1847-65. doi: 10.1002/hbm.22741. Epub 2015 Jan 27.

Driving safely with dementia

Warlow C.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):593-4. doi: 10.1136/jnnp-2015-310325. Epub 2015 Jan 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias